Article Versions Notes

Dadone-Montaudié B, Laroche-Clary A, Mongis A, Chamorey E, Di Mauro I, Chaire V, Finetti P, Schiappa R, Le Loarer F, Birtwisle-Peyrottes I, et al. Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting. Cancers. 2020; 12(10):3058. https://doi.org/10.3390/cancers12103058

Dadone-Montaudié, Bérengère, Audrey Laroche-Clary, Aline Mongis, Emmanuel Chamorey, Ilaria Di Mauro, Vanessa Chaire, Pascal Finetti, Renaud Schiappa, François Le Loarer, Isabelle Birtwisle-Peyrottes, and et al. 2020. "Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting" Cancers 12, no. 10: 3058. https://doi.org/10.3390/cancers12103058

Dadone-Montaudié, B., Laroche-Clary, A., Mongis, A., Chamorey, E., Di Mauro, I., Chaire, V., Finetti, P., Schiappa, R., Le Loarer, F., Birtwisle-Peyrottes, I., Michiels, J.-F., Bertucci, F., Pedeutour, F., Italiano, A., & Bianchini, L. (2020). Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting. Cancers, 12(10), 3058. https://doi.org/10.3390/cancers12103058